Jeff Evans - University of Glasgow | 人才画像

基本信息

Career Trajectory

Bio

My clinical research interests are in the pre-clinical and clinical development of novel anti-cancer agents including molecular targeted therapies and novel therapies for gastro-oesophageal and hepato-biliary-pancreatic cancers and melanoma. We are developing novel laboratory models and bio-markers of anti-tumour activity to specific agents that can be applied to biological samples collected from patients in clinical trials of novel anti-cancer agents.

Research Interests

Papers共 425 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

SPIRIT-DEFINE Explanation and Elaboration: Recommendations for Enhancing Quality and Impact of Early Phase Dose-Finding Clinical Trials Protocols

Moreno Ursino, Guillermo Villacampa,Jan Rekowski,Munyaradzi Dimairo,Olga Solovyeva,Deborah Ashby,Jordan Berlin,Oliver Boix,Melanie Calvert,An-Wen Chan, Courtney H. Coschi,Thomas R. Jeffry Evans,Elizabeth Garrett-Mayer,Robert M. Golub,Christina Guo,Kathryn S. Hayward,Sally Hopewell,John D. Isaacs,S. Percy Ivy,Thomas Jaki,Olga Kholmanskikh,Andrew Kightley,Shing Lee, Rong Liu, Adrian Mander, Lynley Marshall,James Matcham,Dhrusti Patel, Richard Peck,Khadija Rerhou Rantell,Dawn P. Richards, Mahtab Rouhifard, Lesley Seymour, Yoshiya Tanaka,Christopher J. Weir,Johann de Bono,Christina Yap

ECLINICALMEDICINE (2025)

Cited0Views0WOSBibtex

CONSORT-DEFINE Explanation and Elaboration: Recommendations for Enhancing Reporting Quality and Impact of Early Phase Dose-Finding Clinical Trials

Jan Rekowski,Christina Guo,Olga Solovyeva,Munyaradzi Dimairo, Mahtab Rouhifard,Dhrusti Patel,Emily Alger,Deborah Ashby,Jordan Berlin,Oliver Boix,Melanie Calvert,An-Wen Chan, Courtney H. Coschi,Johann de Bono,Thomas R. Jeffry Evans,Elizabeth Garrett-Mayer,Robert M. Golub,Kathryn S. Hayward,Sally Hopewell,John D. Isaacs,S. Percy Ivy,Thomas Jaki,Olga Kholmanskikh,Andrew Kightley,Shing Lee, Rong Liu, Israel Maia, Adrian Mander, Lynley Marshall,James Matcham, Richard Peck,Khadija Rerhou Rantell,Dawn P. Richards, Lesley Seymour, Yoshiya Tanaka,Moreno Ursino,Christopher J. Weir,Christina Yap

ECLINICALMEDICINE (2025)

Cited0Views0WOSBibtex

Abstract PR04: Therapeutic Development Platform for Pancreatic Cancer in the UK National Health Service: Lessons Learned and Initial Results from Precision-Panc

Fieke E. M. Froeling,Juan Valle,Rosie Upstill-Goddard, Paul Grimwood,Paul Westwood,Stephan B. Dreyer,Caroline Kelly,Fraser Duthie, Judith Dixon, Sarah Bradley,T. R. Jeffry Evans,Owen J. Sansom,Andrew V. Biankin,David K. Chang

CANCER RESEARCHno. 2 (2024)

Cited0Views0Bibtex

Ctdna Analysis of Patients (pts) with Unresectable Hepatocellular Carcinoma (uhcc) Treated with Lenvatinib (LEN) or Sorafenib (SOR) As 1L Therapy

T. R. Jeffry Evans,Masatoshi Kudo,Ann-Lii Cheng,Lucjan S. Wyrwicz,Roger Kc Ngan,Jean-Frederic Blanc,Ari David Baron,Arndt Vogel,Masafumi Ikeda,Fabio Piscaglia,Shukui Qin,Taisuke Hoshi, Ryuji Tamaki,Yasuhiro Funahashi,Chinyere E. Okpara,Koji Sagane, Dongyuan Xing,Yukinori Minoshima,Richard S. Finn

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

Cited0Views0Bibtex

A Phase 1a/1b Study of Fostroxacitabine Bralpamide (fostrox) Monotherapy in Hepatocellular Carcinoma and Solid Tumor Liver Metastases

Ruth Plummer,Alastair Greystoke,Gregory Naylor,Debashis Sarker, A. N. M. Kaiser Anam,Hans Prenen,Laure-Anne Teuwen,Eric Van Cutsem,Jeroen Dekervel,Beate Haugk,Thomas Ness,Sujata Bhoi,Malene Jensen,Tom Morris,Pia Baumann, Niclas Sjogren,Karin Tunblad,Hans Wallberg,Fredrik Oberg,Thomas R. Jeffry Evans

JOURNAL OF HEPATOCELLULAR CARCINOMA (2024): 2033-2047

Cited0Views0WOSBibtex

1071Tip Phase I Study of the Investigational CD228 X 4-1BB Costimulatory Antibody Anticalin Bispecific SGN-BB228 (PF-08046049) in Advanced Melanoma and Other Solid Tumors

R. Dummer, A. Daud,T.K. Eigentler,T.R.J. Evans, J. Henry,F.S. Hodi,W.H. Miller,C. Robert,S. Saibil,L. Tachiki, M. Nayeri, B. Xing,J.M. Mehnert

Annals of Oncology (2024): S709

Cited0Views0Bibtex

41P Total Tumor Burden and Radiomics to Evaluate Response in Dose Escalation Studies: Roginolisib (IOA-244), a Highly Selective PI3Kδ Inhibitor in Metastatic Uveal Melanoma Patients

A.M. Di Giacomo, A. Corsi, N. Sindhwani, A. Rasooli, M.H. Nawaz, F. Belmans, C.C. Meca,M. Maio,T.R.J. Evans, A. Santoro,M. Lahn, W. Vos

Immuno-Oncology and Technology (2024): 101001

Cited0Views0Bibtex

666P Final Results of Phase I/II Study of NUC-7738 As Monotherapy and in Combination with Pembrolizumab: Anti-tumor Immune Response in PD-1 Inhibitor-Resistant Patients

S. Blagden,M. Elshani,S.N. Symeonides, A. Skolariki, N.R. Haris, Z.Y. Boh, A. Dickson, I.H. Um, Y. Zhang, F.G. McKissock, E. Oelmann,J. Bloss,N. Cook,T.R.J. Evans,R. Plummer,D.J. Harrison

Annals of Oncology (2024): S523-S524

Cited0Views0Bibtex

650P Initial Results from a Phase I/II Study of BT7480, a Novel Nectin-4/Cd137 Bicycle Tumor-Targeted Immune Cell Agonist, in Patients (pts) with Advanced Solid Tumors

K.P. Papadopoulos, A. Dowlati,J.S. Lopez,J. Rodon,A.I. Spira,M. Stein,M. Zibelman,W.I. Ortuzar Feliu, A. Dickson, A. De, X. Gu, H. Cohen, M. Li, J. Bader, C. Bray, S. Santos, J. Smith, R. Lis,T.R.J. Evans

Annals of Oncology (2024): S513-S514

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn